Literature DB >> 21597919

RAD51C germline mutations in Chinese women with familial breast cancer.

Zhiyuan Pang, Lu Yao, Juan Zhang, Tao Ouyang, Jinfeng Li, Tianfeng Wang, Zhaoqing Fan, Tie Fan, Benyao Lin, Yuntao Xie.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21597919     DOI： 10.1007/s10549-011-1574-3

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN： 0167-6806            Impact factor:   4.872


× No keyword cloud information.
  12 in total

1.  Mutation screening of RAD51C in high-risk breast and ovarian cancer families.

Authors:  Wenping Lu; Xianshu Wang; Hongsheng Lin; Noralane M Lindor; Fergus J Couch
Journal:  Fam Cancer       Date:  2012-09       Impact factor: 2.375

2.  Polymorphic variations in the FANCA gene in high-risk non-BRCA1/2 breast cancer individuals from the French Canadian population.

Authors:  Nadhir Litim; Yvan Labrie; Sylvie Desjardins; Geneviève Ouellette; Karine Plourde; Pascal Belleau; Francine Durocher
Journal:  Mol Oncol       Date:  2012-09-11       Impact factor: 6.603

3.  Germline RAD51C mutations confer susceptibility to ovarian cancer.

Authors:  Chey Loveday; Clare Turnbull; Elise Ruark; Rosa Maria Munoz Xicola; Emma Ramsay; Deborah Hughes; Margaret Warren-Perry; Katie Snape; Diana Eccles; D Gareth Evans; Martin Gore; Anthony Renwick; Sheila Seal; Antonis C Antoniou; Nazneen Rahman
Journal:  Nat Genet       Date:  2012-04-26       Impact factor: 38.330

4.  RAD51C germline mutations in breast and ovarian cancer cases from high-risk families.

Authors:  Jessica Clague; Greg Wilhoite; Aaron Adamson; Adam Bailis; Jeffrey N Weitzel; Susan L Neuhausen
Journal:  PLoS One       Date:  2011-09-28       Impact factor: 3.240

5.  Single nucleotide polymorphisms in noncoding regions of Rad51C do not change the risk of unselected breast cancer but they modulate the level of oxidative stress and the DNA damage characteristics: a case-control study.

Authors:  Peter Gresner; Jolanta Gromadzinska; Ewa Jablonska; Maciej Stepnik; Oscar Zambrano Quispe; Ewa Twardowska; Wojciech Wasowicz
Journal:  PLoS One       Date:  2014-10-24       Impact factor: 3.240

6.  Novel germline mutations and unclassified variants of BRCA1 and BRCA2 genes in Chinese women with familial breast/ovarian cancer.

Authors:  Wen-Ming Cao; Yun Gao; Hong-Jian Yang; Shang-Nao Xie; Xiao-Wen Ding; Zhi-Wen Pan; Wei-Wu Ye; Xiao-Jia Wang
Journal:  BMC Cancer       Date:  2016-02-06       Impact factor: 4.430

7.  Comprehensive mutation detection of BRCA1/2 genes reveals large genomic rearrangements contribute to hereditary breast and ovarian cancer in Chinese women.

Authors:  Wen-Ming Cao; Ya-Bing Zheng; Yun Gao; Xiao-Wen Ding; Yan Sun; Yuan Huang; Cai-Jin Lou; Zhi-Wen Pan; Guang Peng; Xiao-Jia Wang
Journal:  BMC Cancer       Date:  2019-06-07       Impact factor: 4.430

8.  Screening of Finnish RAD51C founder mutations in prostate and colorectal cancer patients.

Authors:  Liisa M Pelttari; Riikka Nurminen; Alexandra Gylfe; Lauri A Aaltonen; Johanna Schleutker; Heli Nevanlinna
Journal:  BMC Cancer       Date:  2012-11-23       Impact factor: 4.430

9.  A dominant RAD51C pathogenic splicing variant predisposes to breast and ovarian cancer in the Newfoundland population due to founder effect.

Authors:  Lesa M Dawson; Kerri N Smith; Salem Werdyani; Robyn Ndikumana; Cindy Penney; Louisa L Wiede; Kendra L Smith; Justin A Pater; Andrée MacMillan; Jane Green; Sheila Drover; Terry-Lynn Young; Darren D O'Rielly
Journal:  Mol Genet Genomic Med       Date:  2019-11-28       Impact factor: 2.183

10.  Rad51 paralogs and the risk of unselected breast cancer: A case-control study.

Authors:  Peter Grešner; Ewa Jabłońska; Jolanta Gromadzińska
Journal:  PLoS One       Date:  2020-01-06       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.